PubMed Health⌕ Search

Biomedical subjects

H M Heffner

Publications and source records attributed to H M Heffner.

2 recordsLinked to original sources

Glomerulonephritis for the generalist.

Glomerulonephritis is a common renal disorder, and a leading cause of end-stage renal disease. Glomerulonephritis can present in protean ways, with general features including proteinuria, hematuria, renal failure, and hypertension. Recent advances in our knowledge of glomerulonephritis have indicated that in many cases early therapeutic intervention can lead to improvement in renal function, long-term preservation of renal function, or slowing of the progression to end-stage renal failure. The goal of this review is to describe the method of evaluation of glomerulonephritis, stress the importance of general measures to preserve renal function or slow the rate of progression of disease, and finally to familiarize the reader with distinct categories of disease and their treatment.

Glomerulonephritis↗

Prognostic significance of p53, PCNA, and c-erbB-2 in endometrial enocarcinoma.

Previous studies of oncogenes, tumor suppressor genes, and proliferation markers in endometrial adenocarcinoma have obtained conflicting results regarding the usefulness of these markers in predicting prognosis. This study examined p53, PCNA, and c-erbB-2 immunohistochemically to clarify the relationship of these markers to each other and to FIGO stage, myometrial invasion, and survival. We studied 64 cases of endometrial carcinoma, treated between 1988 and 1995, for overexpression of p53, percentage of PCNA expression (PCNA index), and c-erbB-2 cytoplasmic membrane staining. Thirty-two percent of tumors expressed p53, 39% displayed a PCNA index of > = 25%, and 69% expressed c-erbB-2. p53 overexpression was significantly associated with stage (p=0.027), PCNA index > = 25% (p=0.005), c-erbB-2 expression (p=0.018), and vital status (p=0.04). PCNA index > = 25% was associated with stage (p=0.008), myometrial invasion (p=0.008), and c-erbB-2 expression (p=0.05), and weakly associated with vital status (p=0.07). No associations were observed for c-erbB-2 with stage, invasion, or vital status. There was some suggestion of a decreased survival in patients whose tumors overexpressed p53 (Log Rank; p=0.09) or had a PCNA index > = 25% (Log Rank; p=0.13). Additional, larger studies are needed to evaluate the prognostic value of PCNA and p53 expression in endometrial adenocarcinoma.

Adenocarcinoma↗